Lymphovascular invasion determines the outcome of stage I colorectal cancer patients

Formosan Journal of Surgery

Volumn 45, Issue 5, 2012, Pages 141-145

  Chang, Shih Ching ^a   Lin, Chun Chi ^a   Wang, Huann Sheng ^a   Yang, Shung Haur ^a   Jiang, Jeng Kai ^a   Lan, Yuan Tzu ^a   Lin, Tzu Chen ^a   Li, Anna Fen Yau ^a   Chen, Wei Shone ^a   Lin, Jen Kou ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Lymphovascular invasion; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL EVALUATION; CLINICAL FEATURE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 84866774235     PISSN: 1682606X     EISSN: 22135413     Source Type: Journal    
DOI: 10.1016/j.fjs.2012.06.006     Document Type: Article

References (23)

1. The Department of Health, the Executive Yuan, Taiwan, R.O.C Cancer Registry Annual Report December 2007.
2. Jessup J.M., Menck H.R., Steele G.D., Menck H.R., Winchester D.P. The National Cancer Data Base. Report on colon cancer. Cancer 1996, 78:918-926.
3. Ju J.H., Chang S.C., Wang H.S., et al. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis 2007, 22:855-862.
4. Engstrom P.F., Arnoletti J.P., Benson A.B., et al. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colon cancer. J Natl Compr Canc Netw 2009, 7:778-831.
5. Iddings D., Ahmad A., Elashoff D., Bilchik A. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 2006, 13:1386-1392.
6. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124:979-994.
7. Edge S.B., Byrd D.R., Compton C.C., et al. AJCC Cancer Staging Manual 2010, Springer, New York, 113-120. 7th ed.
8. O'Connell J.B., Maggard M.A., Ko C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004, 96:1420-1425.
9. Nicastri D.G., Doucette J.T., Godfrey T.E., Hughes S.J. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 2007, 9:563-571.
10. Bilchik A., Nissan A., Wainberg Z., et al. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg 2010, 252:467-474.
11. Mescoli C., Rugge M., Pucciarelli S., et al. High prevalence of isolated tumor cells in regional lymph nodes from pN0 colorectal cancer. J Clin Pathol 2006, 59:870-874.
12. Okabe S., Shia J., Nash G., et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 2004, 8:1032-1039.
13. Nascimbeni R., Burgart L.J., Nivatvongs S., Larson D.R. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002, 45:200-206.
14. Chok K.S., Law W.L. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 2007, 31:1485-1490.
15. Wasif N., Faries M.B., Saha S., et al. Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery 2010, 147:352357.
16. Mroczkowski P., Schmidt U., Sahm M., Gastinger I., Lippert H., Kube R. Prognostic factors assessed for 15,096 patients with colon cancer in stages I and II. World J Surg 2012, 36:1693-1698.
17. Nelson H., Petrelli N., Carlin A., et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001, 93:583-596.
18. Schofield J.B., Mounter N.A., Mallett R., Haboubi N.Y. The importance of accurate pathological assessment of lymph node involvement in colorectal cancer. Colorectal Dis 2006, 8:460-470.
19. Gonen M., Schrag D., Weiser M.R. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 2009, 27:6166-6171.
20. Baxter N.N., Virnig D.J., Rothenberger D.A., Morris A.M., Jessurun J., Virnig B.A. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 2005, 97:219-225.
21. Chang G.J., Rodriguez-Bigas M.A., Skibber J.M., Moyer V.A. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007, 99:433-441.
22. Berger A.C., Watson J.C., Ross E.A., Hoffman J.P. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 2004, 70:235-240.
23. Bui L., Rempel E., Reeson D., Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 2006, 93:439-445.